Healing the Future: Zydus Lifesciences Backs Illexcor's Groundbreaking Sickle Cell Therapy

Unknown Apr 02, 2026 900 Views

Zydus Lifesciences has announced that its venture arm, Zynext Ventures, has invested in Illexcor Therapeutics. This strategic investment aims to advance a novel oral therapy for sickle cell disease, marking a significant step in Zydus' commitment to developing innovative treatments for rare a...

Stay Ahead – Explore Now! Price of Delay: Trump Warns Iran After Slow Peace Talks Break Down